<section id ="1156064-1174044" class="mfp-hide modal-dialog modal-content overlay-def"><header class="modal-header"><h2 class="modal-title">2019, c. 29, s. 169</h2></header><div class="modal-body"><p class="Section amending" id="1156064"><strong><a class="sectionLabel" id="s-169"><span class="sectionLabel">169</span></a></strong> The Act is amended by adding the following after section 21.8:</p><section><div class="AmendedText"><h4 class="SchedHeadL2"><span class="HTitleText2">Advanced Therapeutic Products</span></h4><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Prohibited activities</p><ul class="Section ProvisionList" id=""><li><p class="Subsection"><strong>21.9</strong> <span class="lawlabel">(1)</span> No person shall import, sell, advertise, manufacture, prepare, preserve, package, label, store or test an advanced therapeutic product unless the person</p><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(a)</span> holds a licence in respect of that product that was issued under subsection 21.92(1) and that authorizes the activity in question;</p></li><li><p class="Paragraph"><span class="lawlabel">(b)</span> is authorized under an order made under subsection 21.95(1) to conduct the activity in question in respect of the product; or</p></li><li><p class="Paragraph"><span class="lawlabel">(c)</span> conducts the activity in question in accordance with the regulations.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Clarification</p><p class="Subsection"><span class="lawlabel">(2)</span> For greater certainty, the prohibition applies in respect of an activity regardless of whether the activity is conducted for the purpose of the sale or use of the advanced therapeutic product.</p></li></ul><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Additions to Schedule G</p><ul class="Section ProvisionList" id=""><li><p class="Subsection"><strong>21.91</strong> <span class="lawlabel">(1)</span> For the purpose of preventing injury to health or preventing a person from being deceived or misled, the Minister may, by order, add a description of a therapeutic product or a class of therapeutic products to Schedule G if the Minister believes that the therapeutic product or products represent an emerging or innovative technological, scientific or medical development.</p></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Factors</p><p class="Subsection"><span class="lawlabel">(2)</span> Before adding a description of a therapeutic product or a class of therapeutic products to Schedule G, the Minister shall consider the following factors:</p><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(a)</span> the degree of uncertainty respecting the risks and benefits associated with the therapeutic product or products and the measures that are available to adequately manage and control those risks;</p></li><li><p class="Paragraph"><span class="lawlabel">(b)</span> the extent to which the therapeutic product or products are different from therapeutic products for which therapeutic product authorizations have been issued under the regulations;</p></li><li><p class="Paragraph"><span class="lawlabel">(c)</span> the extent to which existing legal frameworks are adequate to prevent injury to health or to prevent persons from being deceived or misled; and</p></li><li><p class="Paragraph"><span class="lawlabel">(d)</span> the prescribed factors, if any.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Deletion from Schedule G</p><p class="Subsection"><span class="lawlabel">(3)</span> The Minister may, by order, delete the description of a therapeutic product or a class of therapeutic products from Schedule G.</p></li></ul><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Advanced therapeutic product licence</p><ul class="Section ProvisionList" id=""><li><p class="Subsection"><strong>21.92</strong> <span class="lawlabel">(1)</span> Subject to the regulations, the Minister may, on application, issue or amend an advanced therapeutic product licence that authorizes a person to import, sell, advertise, manufacture, prepare, preserve, package, label, store or test an advanced therapeutic product if the Minister believes that the applicant has provided sufficient evidence to support the conclusion that</p><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(a)</span> the benefits associated with the product outweigh the risks; and</p></li><li><p class="Paragraph"><span class="lawlabel">(b)</span> the risks associated with the product and the activity will be adequately managed and controlled.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Application</p><p class="Subsection"><span class="lawlabel">(2)</span> An application for an advanced therapeutic product licence, or for its amendment, shall be filed with the Minister in the form and manner specified by the Minister and shall set out the information required by the Minister as well as any prescribed information.</p></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Terms and conditions</p><p class="Subsection"><span class="lawlabel">(3)</span> The Minister may impose terms and conditions on an advanced therapeutic product licence, including an existing licence, or amend them.</p></li></ul><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Suspension and revocation</p><ul class="Section ProvisionList" id=""><li><p class="Subsection"><strong>21.93</strong> <span class="lawlabel">(1)</span> Subject to the regulations, the Minister may suspend or revoke an advanced therapeutic product licence, in whole or in part, if</p><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(a)</span> the Minister believes that the risks that are associated with the advanced therapeutic product outweigh the benefits;</p></li><li><p class="Paragraph"><span class="lawlabel">(b)</span> the Minister believes that the risks associated with the product or any authorized activity are not being adequately managed or controlled;</p></li><li><p class="Paragraph"><span class="lawlabel">(c)</span> in the case of a suspension, any prescribed circumstance exists; or</p></li><li><p class="Paragraph"><span class="lawlabel">(d)</span> in the case of a revocation, any prescribed circumstance exists.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Suspension without prior notice</p><p class="Subsection"><span class="lawlabel">(2)</span> If the Minister believes that an immediate suspension is necessary to prevent injury to health, the Minister may suspend an advanced therapeutic product licence, in whole or in part, without prior notice to its holder and regardless of whether any of the circumstances referred to in subsection (1) exists.</p></li></ul><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Exemption</p><p class="Section"><strong>21.94</strong> The holder of an advanced therapeutic product licence is, in respect of the activities authorized under the licence, exempt from the provisions of the regulations other than any provisions that are specified in regulations made under paragraph 30(1.2)(b.2).</p><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Order — advanced therapeutic products</p><ul class="Section ProvisionList" id=""><li><p class="Subsection"><strong>21.95</strong> <span class="lawlabel">(1)</span> The Minister may make an order, with or without terms and conditions, that authorizes any person within a class of persons that is specified in the order to import, sell, advertise, manufacture, prepare, preserve, package, label, store or test an advanced therapeutic product.</p></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Additional content</p><p class="Subsection"><span class="lawlabel">(2)</span> The Minister may, in the order,</p><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(a)</span> specify provisions of the regulations that are excluded from the scope of the exemption provided for in section 21.96; and</p></li><li><p class="Paragraph"><span class="lawlabel">(b)</span> establish classes and distinguish among those classes.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Compliance with terms and conditions</p><p class="Subsection"><span class="lawlabel">(3)</span> A person that conducts an activity under the order shall comply with any applicable terms and conditions.</p></li></ul><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Exemption</p><p class="Section"><strong>21.96</strong> A person that conducts an activity under an order made under subsection 21.95(1) is, in respect of the activity, exempt from the provisions of the regulations other than any provisions that are specified in the order or in regulations made under paragraph 30(1.2)(b.2).</p></div></section></div></section>